Recent Publications on Glioma: |  |
Alexander disease: An important mimicker of focal brainstem glioma.
This paper describes a study on the preparation and characterisation of...
Direct Link | 21st November, 2009
| Division of Pediatric Hematology and Oncology, Department of Pediatrics
|
The novel ruthenium-gamma-linolenic complex [Ru(2)(aGLA)(4)Cl] inhibits C6 rat glioma cell proliferation and induces changes in mitochondrial membrane potential, increased reactive oxygen species generation and apoptosis in vitro.
The present study reports the synthesis of a novel compound with the...
Direct Link | 21st November, 2009
| Department of Fundamental Chemistry, University of Sao Paulo, Sao Paulo,
|
The role of microglia in central nervous system immunity and glioma immunology.
The central nervous system (CNS) historically has been considered an...
Direct Link | 21st November, 2009
| Department of Neurological Surgery, University of California at San
|
Probing cellular mechanobiology in three-dimensional culture with collagen-agarose matrices.
The study of how cell behavior is controlled by the biophysical properties...
Direct Link | 21st November, 2009
| Department of Bioengineering, University of California, Berkeley, CA
|
Snail and Cox-2 expressions are associated with WHO tumor grade and survival rate of patients with gliomas.
The transcriptional factor Snail and enzyme cyclo-oxygenase-2 (Cox-2) are...
Direct Link | 21st November, 2009
| Department of Pathology, Seoul National University Hospital, Seoul, Korea.
|
| Expression of p-Akt and COX-2 in Gastric Adenocarcinomas and Adenovirus Mediated Akt1 and COX-2 ShRNA Suppresses SGC-7901 Gastric Adenocarcinoma and U251 Glioma Cell Growth In Vitro and In Vivo.
| 21st November, 2009
| Gastroenterology, Tianjin Medical University General Hospital, 154 An-Shan
|
| Marchantin C: A potential anti-invasion agent in glioma cells.
| 20th November, 2009
| Department of Neurosurgery, Qilu Hospital of Shandong University, Jinan,
|
| CXCL12/CXCR4 promotes motility and proliferation of glioma cells.
| 20th November, 2009
| Centre for Neuroscience and Cell Biology and CIMAGO, University of
|
Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium.
Abstract Objective: Spinal cord tumours are highly malignant and often...
Direct Link | 20th November, 2009
| AntiCancer, Inc., San Diego, CA.
|
| Progesterone, BDNF and Neuroprotection in the Injured CNS.
| 20th November, 2009
| Department of Infection and Immunity, The Medical School, University of
|
In vitro and in vivo biological activity of PEDF against a range of tumors.
Background: Pigment epithelium-derived factor (PEDF) is an emerging...
Direct Link | 20th November, 2009
| University of Melbourne, St. Vincent's Hospital, Department of
|
Functional Modulation of Mitochondria by Eicosapentaenoic Acid Provides Protection against Ceramide Toxicity to C6 Glioma Cells.
Mitochondrial dysfunction and associated apoptosis have been reported in...
Direct Link | 20th November, 2009
| Department of General Surgery, Cathay General Hospital, 280 Section 4,
|
Notch Promotes Radioresistance of Glioma Stem Cells.
Radiotherapy represents the most effective nonsurgical treatments for...
Direct Link | 19th November, 2009
| Department of Surgery, Duke University Medical Center, Durham, NC 27710.
|
| Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry.
| 19th November, 2009
| German Cancer Research Center, Dept of Imaging and Radiooncology,
|
Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.
Background:We evaluated bevacizumab with metronomic etoposide among...
Direct Link | 19th November, 2009
| [1] Department of Surgery, The Preston Robert Tisch Brain Tumor Center,
|
